Skip to market wire
InvestLog
← Back to Stock Events← 返回个股快讯
LLYApproved Product Launch获批产品上市Primary source一手来源Source link原始来源by InvestLog AIInvestLog AI 整理
Event time: 事件时间：
Published: 文章发布：

LLY regulated product launch: Lilly launches the Lilly Change the Course Commitment, aiming to address treatment gaps in diabetes and obesity in LMICsEli Lilly and Company（LLY）正式推出获批药品或治疗产品

LLY regulated product launch: Lilly launches the Lilly Change the Course Commitment, aiming to address treatment gaps in diabetes and obesity in LMICs.

Eli Lilly and Company（LLY）正式推出获批药品或治疗产品。

View LLY stock details ->查看 LLY 个股详情 ->

For information only. Not investment advice.内容仅供参考，不构成投资建议。

Related articles相关阅读

Eli Lilly and Company (LLY) falls 4.34% to $1,137Eli Lilly and Company（LLY）下跌 4.34%，报 $1,137

Stock Price Move · October 8, 2026个股行情异动 · 2026/10/8

Eli Lilly and Company (LLY) rises 4.04% to $1,204Eli Lilly and Company（LLY）上涨 4.04%，报 $1,204

Stock Price Move · October 7, 2026个股行情异动 · 2026/10/7

LLY receives FDA approval for Lilly's OlumiantEli Lilly and Company（LLY）的 Lilly's Olumiant 获美国 FDA 批准

Material Company Event · September 25, 2026公司公告 · 2026/9/25